about
Genetic alteration and gene expression modulation during cancer progressionThe diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesionsS100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breastPutative biomarkers and targets of estrogen receptor negative human breast cancerMultidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certificationOverexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinomaProteomics and mass spectrometry for cancer biomarker discoveryQuantitative proteomics employing primary amine affinity tagsPeroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis B virus related liver fibrosis identified by proteomic analysis of the plasmaGene profiling of cottontail rabbit papillomavirus-induced carcinomas identifies upregulated genes directly Involved in stroma invasion as shown by small interfering RNA-mediated gene silencingBcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.RCL2, a new fixative, preserves morphology and nucleic acid integrity in paraffin-embedded breast carcinoma and microdissected breast tumor cells.Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry.Do serum biomarkers really measure breast cancer?A Comparison of the Proteomic Expression in Pooled Saliva Specimens from Individuals Diagnosed with Ductal Carcinoma of the Breast with and without Lymph Node InvolvementIdentification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomicsAlteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype.In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontologyAlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer.Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the BreastIs the small heat shock protein alphaB-crystallin an oncogene?Laser capture microdissection for protein and NanoString RNA analysis14-3-3ζ as a prognostic marker and therapeutic target for cancerReduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of seleniumDifferential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics.The changing role of pathology in breast cancer diagnosis and treatment.c-Fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesisMolecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non-triple-negative breast cancers.Classification of ductal carcinoma in situ by gene expression profiling.Screening for therapeutic targets of vorinostat by SILAC-based proteomic analysis in human breast cancer cells.Ductal carcinoma in situ: recent advances and future prospects.Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer.Human monocytes augment invasiveness and proteolytic activity of inflammatory breast cancer.Application of proteomics in the study of tumor metastasis.Breast tumor metastasis: analysis via proteomic profiling.Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft modelA Catalogue of Altered Salivary Proteins Secondary to Invasive Ductal Carcinoma: A Novel In Vivo Paradigm to Assess Breast Cancer ProgressionThree-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins.
P2860
Q24798750-02C6836A-B0F8-4DEE-A081-3792FE3C946EQ24803014-6ACB361E-CCD2-4D19-9FB6-669A8AE90690Q24805971-2787B61B-E78A-473C-83D1-E7A8C0796A4DQ27003285-E71A45B3-55D8-4E6F-A090-EE3014BA50C1Q27025430-62EC77CC-EBA0-42E1-89EE-89FD05C9E800Q28285857-B10E9B68-83FD-4586-BF15-22DB32BDBB4DQ28766969-1A49DEC1-B0B0-472F-914E-1EF0AB7A82A1Q30988065-D3593724-5A37-4FA2-9C98-AE4AD2DEB8CDQ30990299-05E2928C-FCD7-40A9-A97A-4E27EE96FEEAQ33204255-514B87DC-D375-44DD-9527-4C3DD3965B25Q33224181-227B0695-DAFE-46E7-9156-1EA065CDD673Q33236750-59228783-CA70-41EB-AB24-2171B724ACB0Q33241448-3A014F1C-D56F-4F34-9565-8BFD805A38E8Q33327496-3BDC99CA-6D30-42F0-A5AA-345BB2936BBFQ33454967-932B84FF-5069-4C77-BD40-1EAE1D999B71Q33568539-DA8BF094-F366-4E57-B47E-DB35B04A46C2Q33591231-1CBA8B5E-A428-46E6-B784-FEE2330E33B3Q33625197-CA018D2B-86CB-4294-8AAD-5F0C6AAB5077Q33672680-AFDB551C-9191-4E82-A752-AC6E4FAE66F9Q33992717-8B1075A1-CE15-4C0C-A856-A4E18B12A95DQ34207931-8460B803-B148-4789-9B7E-3926B518A450Q34245398-B5387157-A19B-4209-BF1E-1E5CD8D9433AQ34425869-E2DD0BD7-A0F1-4799-BB18-987A6D6D71B1Q34473399-6A282FE4-3E4E-462E-87D1-5D50E716ACAAQ34737626-6D44A9F9-0A5D-4FBC-B758-6C570393C67FQ34972287-57D74507-A2EE-4BB4-8DFE-FC79A818877EQ35082260-056B24F2-EDE2-47EE-8515-77E3C8452591Q35084895-310207F7-1A9D-4121-B569-DD9B41ACE41AQ35165997-C760A633-338F-4B87-AD09-8B0E71E60C6CQ35589437-C2D2319E-7F82-4955-89F3-F1E74B0107CFQ35605885-8964233D-8F12-4E04-9AD9-F15FC96AA734Q35914300-1C98FA6E-42E9-487D-B685-87747DC39D59Q35996817-DBA1F345-2B2E-40C7-B056-296B9FAFBDF5Q36105177-15624E01-BB37-4E40-ACF9-D0A5A3497473Q36109380-751C5BAB-927F-4D2A-80C8-E3BE8BCD302BQ36111028-A3B45070-168E-4A77-9594-A88E85A918AFQ36146166-5217A4AE-632D-455F-9633-2DAE6290BB05Q36394968-4056DD01-614E-4732-86C4-0D54FD36DF55Q37141148-59542D52-3AAB-43C9-8D90-3776ADD7A3BFQ37212428-0249BA05-27C9-4F30-BE6C-657D171865A1
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Proteomics of human breast ductal carcinoma in situ.
@ast
Proteomics of human breast ductal carcinoma in situ.
@en
type
label
Proteomics of human breast ductal carcinoma in situ.
@ast
Proteomics of human breast ductal carcinoma in situ.
@en
prefLabel
Proteomics of human breast ductal carcinoma in situ.
@ast
Proteomics of human breast ductal carcinoma in situ.
@en
P2093
P1433
P1476
Proteomics of human breast ductal carcinoma in situ
@en
P2093
Aysegul Sahin
Dennis C Sgroi
Diethelm Wallwiener
Emanuel F Petricoin
Henry Krutzsch
Hongjun Shu
Julia D Wulfkuhle
Kelley McLean
Kelly McGarvey
Maria J Merino
P304
P407
P577
2002-11-01T00:00:00Z